by Greg Kuehn | Mar 20, 2020 | Research News
Research will examine prevalent gut microbial markers present in colorectal cancer CARLSBAD, Calif., June 2, 2020 /PRNewswire/ — Prescient Metabiomics, a subsidiary of Prescient Medicine Holdings, Inc., announced today a research...
by Greg Kuehn | Dec 10, 2013 | Research News
POTOMAC FALLS, VA, December 10, 2013 Metabiomics is pioneering the development of molecular diagnostic tests for colorectal cancer, inflammatory bowel disease, and other gastrointestinal cancers and autoimmune diseases built on an exclusive worldwide license from...
by Greg Kuehn | Sep 21, 2012 | Press Releases
Metabiomics Selected to Present Molecular Diagnostic Innovations and Growth Strategy at Annual Mid-Atlantic BIO Conference Potomac Falls, Virginia (September 17, 2012) Metabiomics, a Northern-VA-based molecular diagnostics firm, was selected by the Mid-Atlantic Bio...
by Greg Kuehn | Jun 15, 2011 | Press Releases, Research News
It is not often that health sciences takes off in leaps and bounds on a whole new branch of discovery. Systems Biology scientists are exploring the Metagenome and Microbiome of Humans to map their interactive genetic and metabolic functions.We define the complex...
